Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIAI
AIAI
$14.00
-6.4%
$0.00
$11.12
$16.85
N/AN/A448,733 shs236,170 shs
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$0.26
-2.9%
$0.32
$0.05
$0.81
N/AN/A2,513 shs4,332 shs
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
$0.07
$0.06
$0.01
$0.32
N/AN/A18,321 shsN/A
DKDCW
Data Knights Acquisition
$0.05
$0.06
$0.01
$0.09
N/AN/A56,534 shsN/A
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIAI
AIAI
-6.42%+1,399,999,900.00%+1,399,999,900.00%+1,399,999,900.00%+1,399,999,900.00%
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
-2.95%+12.72%-22.12%+13.82%+129.46%
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
0.00%+10.17%-7.14%+8.33%+53.62%
DKDCW
Data Knights Acquisition
0.00%+40.19%+19.05%-57.14%+56.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIAI
AIAI
$14.00
-6.4%
$0.00
$11.12
$16.85
N/AN/A448,733 shs236,170 shs
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$0.26
-2.9%
$0.32
$0.05
$0.81
N/AN/A2,513 shs4,332 shs
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
$0.07
$0.06
$0.01
$0.32
N/AN/A18,321 shsN/A
DKDCW
Data Knights Acquisition
$0.05
$0.06
$0.01
$0.09
N/AN/A56,534 shsN/A
The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIAI
AIAI
-6.42%+1,399,999,900.00%+1,399,999,900.00%+1,399,999,900.00%+1,399,999,900.00%
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
-2.95%+12.72%-22.12%+13.82%+129.46%
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
0.00%+10.17%-7.14%+8.33%+53.62%
DKDCW
Data Knights Acquisition
0.00%+40.19%+19.05%-57.14%+56.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIAI
AIAI
0.00
N/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
0.00
N/AN/AN/A
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
0.00
N/AN/AN/A
DKDCW
Data Knights Acquisition
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIAI
AIAI
$272.00MN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$5.61MN/AN/AN/AN/AN/A
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
N/AN/AN/AN/AN/AN/A
DKDCW
Data Knights Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIAI
AIAI
N/AN/AN/AN/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/AN/AN/AN/A5/20/2026 (Estimated)
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
N/AN/AN/AN/AN/AN/AN/AN/AN/A
DKDCW
Data Knights Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AIAI
AIAI
N/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/A
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
N/AN/AN/AN/AN/A
DKDCW
Data Knights Acquisition
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIAI
AIAI
2N/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
10N/AN/ANot Optionable
CF Acquisition Corp. VIII stock logo
CFFEW
CF Acquisition Corp. VIII
3N/AN/ANot Optionable
DKDCW
Data Knights Acquisition
2N/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Media Sentiment Over Time

AIAI NASDAQ:AIAI

$14.00 -0.96 (-6.42%)
Closing price 05/18/2026 04:00 PM Eastern
Extended Trading
$13.32 -0.68 (-4.86%)
As of 08:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AIAI was formed for the purpose of creating an AI-powered ecosystem through acquiring and scaling companies that have high potential for increased operating results through the integration of our Artificial Intelligence, or AI into their operations. We are not simply an investment vehicle—we seek to improve the operating performance of our subsidiaries through the application of our proprietary AI. The AI that we will apply to the companies that we acquire will be licensed to us by Messier 42 LLC, or M42, a company controlled by our founder, John P. Rochon, immediately prior to the effective date, or the Effective Date, of the Registration Statement of which this prospectus forms a part. AIAI will identify, acquire, and, where appropriate, consolidate high potential, AI-adjacent companies through a thorough evaluation framework that looks beyond conventional metrics. Our unique assessment methodology is designed to identify hidden value that traditional approaches miss, creating opportunities for increased stockholder returns. We expect to generate value through strong leadership coupled with technological integration, and unlocking synergies between AI and operations that remain invisible to traditional approaches. By combining complementary capabilities, we create solutions that are greater than the sum of their parts. The global technological landscape is experiencing a fundamental shift as the industry reaches the critical threshold where AI transforms from a promising technology to a transformative force. Through our access to M42’s proprietary integrated AI, we expect to be able to capitalize on what we see as the convergence of advanced AI, mature computing infrastructure, and market readiness. AIAI’s strategic thesis rejects the siloed application of AI and instead focuses on building an integrated ecosystem where specialized capabilities amplify each other across multiple verticals such as construction, healthcare, defense, blockchain data infrastructure, digital assets, and government services. Our operating strategy is based on the premise that we anticipate generating a higher usage rate for our AI technology through applying it directly to the operations of our wholly-owned subsidiaries, which we believe will create greater stockholder value. We expect to implement this process through the acquisition of companies with AI integration potential as opposed to the generally accepted industry practice of marketing, selling and negotiating individual license agreements with multiple unrelated clients. By creating a captive client base through targeted entity acquisitions, consisting of those that we that acquire immediately prior to the Effective Date and those we acquire thereafter, we expect to be able to implement our AI solutions in a shorter time period (which we anticipate will take four to six months following the acquisition of the target entity) as compared to the significantly longer time required to establish a third-party licensing arrangement which in our experience can last as long as or more than 24 months to complete the full integration process. Additionally, we believe our acquisition versus licensing strategy will result in a reduced execution risk and lower pursuit costs than negotiating third-party technology licenses. A study conducted by Everest Research stated that 90% of all successful AI pilot projects were never implemented. AIAI is not just participating in the evolution of the “cognitive revolution,” it is helping to shape it. By integrating diverse companies into a cohesive AI ecosystem, the company expects to unlock value traditional models cannot replicate. We expect to build a shared intelligence layer across our portfolio to build reusable profiles of people, processes, and industries to predict outcomes and deepen relationships. The company anticipates developing reusable profiles of how individuals think and behave, applying common analytical methods across businesses, detecting cross-company patterns invisible to single datasets, and recommending progressions of products matching individual needs. For example, in construction bidding, the system will analyze project history, team psychometrics, and procurement data to produce accurate estimates with quantified confidence factors, accounting for how project type, geography, and team composition affect delivery, thereby helping firms avoid unsustainable low bids. We believe the creation of a shared knowledge base differentiates our model from traditional AI models that typically operate in isolation, being trained for specific tasks within single companies or domains and thereby only creating siloed solutions. With a clear vision, robust portfolio, and actionable roadmap, AIAI believes it is poised to redefine industries and deliver significant value to its stockholders. Our licensed AI brings together the branches of mathematics, science, and engineering in a loosely coupled software platform that we believe can be applied to reveal undiscerned patterns and intelligence almost anywhere. We believe the following characteristics set us apart from our competitors: . Proven Management Team: John P. Rochon, the Chairman of our Board of Directors, along with the members of our management team, bring a track record of an aggregate of over 100 years of successful technology implementation and business transformation, generating consistent returns through the acquisition, reorganization and disposition of approximately 350 separate companies across multiple industry segments. . Accelerated Implementation: Through the acquisition of the companies to which our AI will be implemented rather than engaging in what are frequently protracted licensing negotiations, we expect to be able to more rapidly implement our AI solutions than our competitors. . M42 Behavioral, Math, and Science AI Platform: The M42 AI Technology, to which the company has access through a license agreement with M42, provides us such analytic tools as predictive modeling and pattern recognition, as well as many other proprietary AI fields to identify opportunities invisible to traditional analytics. . Cross-Vertical Perspective: Our acquisition strategy identifies target entities in multiple industry sectors, allowing the company to combine diverse capabilities to create synergistic value at industry intersections. . Shared Experiences of and Lessons Learned by Portfolio Company Management: As the management teams of our Portfolio Companies complete implementation of our licensed AI technology, they will be able to share their experiences and lessons learned with the leadership of our future acquisitions which should facilitate accelerated implementation of the AI and improvements in operations. . Ethical AI Leadership: Our operating strategy prioritizes responsible development with transparent, human-centric solutions. Our principal executive offices are located in Dallas, Texas.

bioAffinity Technologies stock logo

bioAffinity Technologies NASDAQ:BIAFW

$0.26 -0.01 (-2.95%)
Closing price 05/18/2026 03:45 PM Eastern
Extended Trading
$0.26 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

CF Acquisition Corp. VIII stock logo

CF Acquisition Corp. VIII NASDAQ:CFFEW

$0.06 0.00 (0.00%)
As of 05/15/2026

XBP Europe Holdings, Inc. provides bills, payments, and related solutions and services in France, Germany, the United Kingdom, Sweden, and internationally. It offers XBP platform that provides secure messaging services; request to pay solutions; enterprise information management solutions; digital mailroom and records digitization solutions; business process management and intelligent workflow automation solutions; integrated communications solution; banking and financial industry solutions and services; cross-border payments; digitization of checks; confirmation of payee; and mortgage and loan management solutions. The company is based in New York, New York. XBP Europe Holdings, Inc operates as a subsidiary of Exela Technologies, Inc.

Data Knights Acquisition NASDAQ:DKDCW

$0.04 0.00 (0.00%)
As of 05/15/2026

Data Knights Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.